Co-amilozide

Co-amilozide

Combination of
Amiloride	Potassium-sparing diuretic
Hydrochlorothiazide	Thiazide diuretic
Clinical data
AHFS/Drugs.com	International Drug Names
Routes of administration	Oral
ATC code	C03EA01 (WHO)
Legal status
Legal status	UK: POM (Prescription only)
Identifiers
PubChem (CID)	107748
ChemSpider	96911 Y
(verify)

Co-amilozide (BAN) is a non-proprietary combination of amiloride and hydrochlorothiazide. Co-amilozide is used in the treatment of hypertension and congestive heart failure with the tendency of the thiazide to cause low potassium levels (hypokalaemia) offset by the potassium-sparing effects of amiloride.

Formulation

Two strengths of co-amilozide are currently available in the UK:^[1]

• 2.5 mg amiloride and 25 mg hydrochlorothiazide, BAN of Co-amilozide 2.5/25 (brand name Moduret 25)
• 5 mg amiloride and 50 mg hydrochlorothiazide, BAN of Co-amilozide 5/50 (brand name Moduretic)

In North America:

• Moduretic (U.S., Canada)
  • Moduretic 5-50 (U.S., Canada)
• Novamilor (Canada)

Side effects

The most common side effect is headache (about 8% of people taking it) and nausea, loss of appetite, weakness, rash and dizziness (each about 3%).^[2]

Common side effects (1/10 - 1/100) include:^[2]

• General: Weakness, fatigue, loss of appetite. Headache, dizziness.
• Circulatory system: Arrhythmia.
• Gastrointestinal: Nausea, diarrhea, abdominal pain.
• Skin: Exanthema, itching.
• Respiratory system: dyspnoea, cough.
• Metabolic.: Hyperglycemia in diabetic patients, hyperuricemia.
• Musculoskeletal.: Pain in the limbs.

References